Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression

• Xinlei Li ,

  Contributed equally to this work with: Xinlei Li, Yan Liu, Zhiqian Wang

  Roles Conceptualization, Investigation, Writing – original draft

  Affiliation Medical College of Qingdao University, Qingdao, China

  ⨯
• Yan Liu ,

  Contributed equally to this work with: Xinlei Li, Yan Liu, Zhiqian Wang

  Roles Data curation, Investigation, Resources

  Affiliation Department of Pathology, The 971 Hospital of People’s Liberation Army Navy, Qingdao, China

  ⨯
• Zhiqian Wang ,

  Contributed equally to this work with: Xinlei Li, Yan Liu, Zhiqian Wang

  Roles Data curation, Investigation

  Affiliation Department of Molecular Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China

  ⨯
• Xiaocui Bu,

  Roles Formal analysis, Investigation

  Affiliation The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, China

  ⨯
• Yu Wang,

  Roles Data curation

  Affiliation Medical College of Qingdao University, Qingdao, China

  ⨯
• Wei Zhang ,

  Roles Conceptualization, Resources, Validation, Writing – review & editing

  * E-mail: zp8102@126.com (PZ); zhangwei686538@126.com (WZ)

  Affiliation Department of Pathology, The 971 Hospital of People’s Liberation Army Navy, Qingdao, China

  ⨯
• Peng Zhao

  Roles Funding acquisition, Project administration, Supervision, Validation, Writing – review & editing

  * E-mail: zp8102@126.com (PZ); zhangwei686538@126.com (WZ)

  Affiliation Department of Molecular Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China

  https://orcid.org/0000-0001-5208-5809

  ⨯